146 related articles for article (PubMed ID: 16971401)
1. Antibiotic susceptibility of Neisseria gonorrhoeae in Arkhangelsk, Russia.
Vorobieva V; Firsova N; Ababkova T; Leniv I; Haldorsen BC; Unemo M; Skogen V
Sex Transm Infect; 2007 Apr; 83(2):133-5. PubMed ID: 16971401
[TBL] [Abstract][Full Text] [Related]
2. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.
Kubanova A; Frigo N; Kubanov A; Sidorenko S; Priputnevich T; Vachnina T; Al-Khafaji N; Polevshikova S; Solomka V; Domeika M; Unemo M
Sex Transm Infect; 2008 Aug; 84(4):285-9. PubMed ID: 18256105
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
[TBL] [Abstract][Full Text] [Related]
4. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.
Bala M; Ray K; Gupta SM; Muralidhar S; Jain RK
J Antimicrob Chemother; 2007 Sep; 60(3):582-6. PubMed ID: 17604320
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
Vandepitte J; Hughes P; Matovu G; Bukenya J; Grosskurth H; Lewis DA
Sex Transm Dis; 2014 Apr; 41(4):233-7. PubMed ID: 24622633
[TBL] [Abstract][Full Text] [Related]
7. Characterization of multiresistant strains of Neisseria gonorrhoeae isolated in Nicaragua.
Castro I; Bergeron MG; Chamberland S
Sex Transm Dis; 1993; 20(6):314-20. PubMed ID: 8108753
[TBL] [Abstract][Full Text] [Related]
8. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago.
Castor D; Prabhakar P; Furlonge C; Rao A; Brown A; Camara B; Weiss H; Jolly PE
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):987-95. PubMed ID: 11785665
[TBL] [Abstract][Full Text] [Related]
10. Resistance trends in Neisseria gonorrhoeae in southwestern Ohio.
Herchline TE; Inkrott BP
Sex Transm Dis; 2010 Feb; 37(2):121-2. PubMed ID: 19901861
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
[TBL] [Abstract][Full Text] [Related]
13. Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing.
Palmer HM; Young H; Graham C; Dave J
Sex Transm Infect; 2008 Aug; 84(4):280-4. PubMed ID: 18256103
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility profile of Neisseria gonorrhoeae isolated from patients attending a STD facility in Maputo, Mozambique.
Apalata T; Zimba TF; Sturm WA; Moodley P
Sex Transm Dis; 2009 Jun; 36(6):341-3. PubMed ID: 19556927
[TBL] [Abstract][Full Text] [Related]
15. Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
Brunner A; Nemes-Nikodem E; Mihalik N; Marschalko M; Karpati S; Ostorhazi E
BMC Infect Dis; 2014 Aug; 14():433. PubMed ID: 25098185
[TBL] [Abstract][Full Text] [Related]
16. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany.
Horn NN; Kresken M; Körber-Irrgang B; Göttig S; Wichelhaus C; Wichelhaus TA;
Int J Med Microbiol; 2014 Jul; 304(5-6):586-91. PubMed ID: 24801146
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
[TBL] [Abstract][Full Text] [Related]
19. Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines.
Farhi D; Hotz C; Poupet H; Gerhardt P; Morand P; Poyart C; Sednaoui P; Avril MF; Dupin N
Acta Derm Venereol; 2009; 89(5):484-7. PubMed ID: 19734973
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004.
Stathi M; Flemetakis A; Miriagou V; Avgerinou H; Kyriakis KP; Maniatis AN; Tzelepi E
J Antimicrob Chemother; 2006 Apr; 57(4):775-9. PubMed ID: 16492719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
